1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Global Gene Amplification Technologies Industry

Global Gene Amplification Technologies Industry

  • October 2020
  • 293 pages
  • ID: 5817590
  • Format: PDF
  • Global Industry Analysts


Table of Contents


Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

Accurate Results from Small Samples. Dominance of PCR Based COVID-19 Tests Gives Gene Amplification a 31.7% Boost

The global market for Gene Amplification Technologies is forecast to witness revenues spike by over 31.7% in the year 2020 and thereafter continue to grow to reach US$6.8 billion by the year 2027, trailing a post COVID-19 CAGR of 11.4% over the analysis period 2020 through 2027. Gene amplification typically uses Polymerase Chain Reaction (PCR) which remains the most commonly used and effective technology since it permits researchers to obtain lots of gene replicas quickly. Fueled by the introduction of novel PCR instruments for the detection of several critical diseases, Polymerase Chain Reaction (PCR) continues to dominate the gene amplification market. Polymerase chain reaction technology was introduced to the market in 1980s. The technology is used to detect the type and amount of virus or bacteria present in biological samples and also allows amplification of genetic material in large quantities.

In the midst of the ongoing pandemic, diagnostic and antibody tests hold a critical role in identifying people with COVID-19 infection to support isolation or quarantine measures. These tests are expected to help governments in rapidly identifying and isolating infected people and tracking contacts to manage the situation. Molecular diagnostic tests available on the market rely on RT-PCR technology to target specific genomic parts of the virus for accurate, reliable detection. PCR-based techniques are capable of detecting low quantities of viral RNA to deliver high sensitivity and allow timely diagnosis of the COVID-19 infection. Current growth in the gene amplification market is therefore being driven by qPCR technique, closely followed by RT-PCR (Reverse Transcription PCR), the two most widely used testing technologies for COVID-19 disease. A lion’s share of the millions of COVID-19 tests performed worldwide is accounted for by PCR based tests. Polymerase Chain Reaction (PCR) remains the most commonly used & effective technology for gene amplification as the technology permits researchers to create lots of gene replicas very quickly. The technology allows amplification of genetic material in large quantities and is cost-effective & has a rapid turnover rate. 10 months into the pandemic & with infections continuing to spread, the focus on testing, testing & testing promises to raise revenue potential for the technology by a massive 31.7% in the year 2020. Regionally, North America represents the largest market for PCR and is expected to retain its dominance, with the US remaining the single largest market.

The market also stands to benefit from the growing popularity of molecular diagnostics for cancer screening and infectious disease testing such as hepatitis B and C, HIV, flu virus and human papilloma virus. According to the W.H.O, more than 10 million people are expected to die of cancer by the year 2026. The market for oncology-specific molecular diagnostics is dominated by breast cancer, which has a share of 15% in the overall test volumes. There are several commercialized molecular diagnostic products available for breast cancer. Fastest growth in future however is expected to be reported by colorectal cancer. Molecular diagnostic markets for prostate cancer and liver cancer are also anticipated to see major growth in the coming years due to increasing prevalence of these cancer types. People suffering from various infectious diseases, such as GI, STDs, and respiratory diseases are also increasing in numbers. These grave statistics, though alarming, represent growth drivers for the latest diagnostic techniques and devices, including molecular diagnostics based on gene amplification. PCR assays detect the presence of organisms such as Chlamydia, mycoplasmas, mycobacteria, Herpes viruses and enteroviruses from clinical specimens. Commercial PCR assays for the diagnosis of tuberculosis and C. trachomatis infection are routinely used in diagnostic laboratories. PCR assay also detects antimicrobial resistance and are used to identify the cause of infection.

Competitors identified in this market include, among others,
  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Charles River Laboratories International, Inc.
  • Eppendorf AG
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • PerkinElmer, Inc.
  • Promega Corporation
  • Roche Diagnostics Corporation
  • Sysmex Corporation
  • Takara Bio, Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

2020-2025 U.K. Molecular Diagnostics Database: Market Shares and Forecasts for 100 Tests--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 2450
  • December 2020
  • 1 pages

2020-2025 U.K. Molecular Diagnostics Database: Market Shares and Forecasts for 100 Tests--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing This database provides the 2020 supplie ...

  • United Kingdom
  • Genetic Disorder
  • Molecular Diagnostics
  • Industry analysis


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on